Related Experiment Video

Updated: Aug 3, 2026

Myo-mechanical Analysis of Isolated Skeletal Muscle
08:42

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 23, 2011

A signaling role for dystrophin: inhibiting skeletal muscle atrophy pathways

David J Glass1

  • 1Novartis Institutes for Biomedical Research, 400 Technology Square, Cambridge, Massachusetts 02139, USA. david.glass@novartis.com

Cancer Cell
|November 16, 2005
PubMed

Insights

Cancer causes skeletal muscle atrophy by altering protein balance. A new study reveals dystrophin, a protein linked to muscular dystrophy, plays a key role in regulating muscle size by connecting structural integrity to cellular signaling pathways.

Area of Science:

  • Oncology
  • Cellular Biology
  • Muscle Physiology

Background:

  • Skeletal muscle atrophy is a frequent complication in cancer patients.
  • Muscle size is regulated by a balance between protein breakdown (atrophy) and protein synthesis (hypertrophy) pathways.

Discussion:

  • Acharyya et al. identify a novel regulatory mechanism for muscle size control.
  • This axis involves dystrophin, a protein typically associated with muscular dystrophy.
  • The findings reposition dystrophin as a critical signaling protein.

Key Insights:

  • Dystrophin links muscle structural integrity complexes to pathways controlling muscle mass.
  • This discovery provides a new perspective on the cellular mechanisms underlying cancer-induced muscle atrophy.
  • The study highlights the multifaceted role of dystrophin beyond its structural function.

Outlook:

  • Further research may explore therapeutic strategies targeting this dystrophin-centered axis to combat cancer cachexia.
  • Understanding this signaling pathway could lead to interventions for other muscle-wasting conditions.
  • This work opens new avenues for investigating the interplay between muscle structure and cellular signaling in disease.

More Related Videos

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

Immunolabelling Myofiber Degeneration in Muscle Biopsies06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...